Cathepsin G is a neutrophil-derived
serine protease that contributes to tissue damage at sites of
inflammation. The actions of
cathepsin G are reported to be mediated by
protease-activated receptor (PAR)-4 (a
thrombin receptor) in human platelets. This study provides the first evidence that
cathepsin G promotes
inositol 1,4,5-trisphosphate accumulation, activates ERK,
p38 MAPK, and AKT, and decreases contractile function in cardiomyocytes. Because some
cathepsin G responses mimic cardiomyocyte activation by
thrombin, a role for PARs was considered.
Cathepsin G markedly activates
phospholipase C and
p38 MAPK in cardiomyocytes from PAR-1-/- mice, but it fails to activate
phospholipase C, ERK,
p38 MAPK, or AKT in PAR-1- or PAR-4-expressing PAR-1-/- fibroblasts (which display robust responses to
thrombin). These results argue that PAR-1 does not mediate the actions of
cathepsin G in cardiomyocytes, and neither PAR-1 nor PAR-4 mediates the actions of
cathepsin G in fibroblasts. Of note, prolonged incubation of cardiomyocytes with
cathepsin G results in the activation of
caspase-3, cleavage of FAK and AKT, sarcomeric disassembly, cell rounding, cell detachment from underlying matrix, and morphologic features of apoptosis. Inhibition of
Src family kinases or
caspases (with PP1 or benzyloxycarbonyl-VAD-fluoromethyl
ketone, respectively) delays FAK and AKT cleavage and cardiomyocyte detachment from substrate. Collectively, these studies describe novel cardiac actions of
cathepsin G that do not require PARs and are predicted to assume functional importance at sites of interstitial
inflammation in the heart.